Add BrightSurf on Google Email

NYU Langone Health / NYU Grossman School of Medicine


Opioid relapse rates fall with use of medication for adults in criminal justice system

A randomized controlled clinical trial found that extended-release naltrexone significantly prevented relapses in men with previous criminal justice system involvement. The study showed a significant reduction in heroin and opioid use, as well as no overdoses during the six-month treatment period.

SourceNYU Langone Health / NYU Grossman School of Medicine·JournalNew England Journal of Medicine·DateMar 30, 2016

Sleep changes seen with fetal alcohol exposure partly explain learning and mood problems

A new study suggests that fetal alcohol exposure leads to long-lasting slow-wave sleep fragmentation, which is associated with learning problems and impaired cognitive function. The researchers found that mice exposed to binge amounts of ethanol displayed severe sleep fragmentation, memory impairment, and hyperactivity.

Water dispensers in NYC public schools associated with student weight loss

The study, which analyzed over one million students in 1,227 elementary and middle schools across the city, found that students at schools with water jets experienced a reduction in standardized body mass index (zBMI) and the likelihood of being overweight. Easy access to water led kids to substitute it for caloric beverages.

Marijuana derivative reduces seizures in people with treatment-resistant epilepsy

A new open-label trial of prescription cannabidiol (CBD) shows significant reduction in seizure frequency and well-tolerated for most children and young adults. The study also found a sufficient safety profile with minimal adverse events, but more research is needed to definitively recommend CBD as a treatment.

NYU Langone enhances patient experience by reducing referrals to facilities after surgery

A new study from NYU Langone found that reducing post-surgery care referrals to facilities did not increase readmission rates, while improving patient recovery and reducing costs. The hospital implemented a program to discharge more patients home for recovery, with significant drops in facility referrals.

SourceNYU Langone Health / NYU Grossman School of Medicine·JournalJAMA Internal Medicine·DateNov 23, 2015

Big pharma inconsistent with disclosure of information on clinical trials, new study finds

A new study ranks drugs based on their transparency and ethical practices, finding that nearly half of all reviewed drugs had undisclosed Phase II or III trials. The 'Good Pharma Scorecard' aims to incentivize pharmaceutical companies to improve disclosure, benefiting consumers and protecting human research subjects.

National survey of Americans' health app use shows technology's promise and weakness

A national survey of 1,604 adult smartphone users found that 58% had downloaded a health-related mobile application, with 65% reporting improved health. However, concerns about cost, disinterest, and privacy barriers hinder wider adoption. More research is needed to maximize the impact of health apps on overall health.

SourceNYU Langone Health / NYU Grossman School of Medicine·JournalJournal of Medical Internet Research·DateNov 3, 2015

Popular hypertension drugs linked to worse heart health in blacks compared to whites

A new comparative effectiveness research study found that African Americans with high blood pressure have poorer cardiovascular outcomes when treated with ACE inhibitors compared to white patients. The study analyzed data from nearly 60,000 patients and found a significant racial disparity in the effectiveness of these drugs.

SourceNYU Langone Health / NYU Grossman School of Medicine·JournalJournal of the American College of Cardiology·DateSep 15, 2015

Study points to a possible new pathway toward a vaccine against MRSA

A new study by NYU Langone Health has found that the presence or absence of dueling toxins in Staphylococcus aureus bacteria explains why hospital-acquired MRSA is more deadly than community-acquired forms. The study reveals a key toxin that counteracts another, more deadly toxin, opening up possible new pathways for vaccine development.

SourceNYU Langone Health / NYU Grossman School of Medicine·JournalNature Communications·DateSep 9, 2015

'Happy Meals' bill could improve healthfulness of fast food meals for kids in NYC

A new study by NYU Langone Medical Center researchers finds that a 'Healthy Happy Meals' bill could reduce calories, fat, and sodium in fast food meals marketed to children. The proposed legislation requires fast food meals for kids to include a serving of fruit or vegetables and be limited to 500 calories or less.

SourceNYU Langone Health / NYU Grossman School of Medicine·JournalAmerican Journal of Preventive Medicine·DateAug 31, 2015

New method of closing the incision during scoliosis surgery nearly eliminates infections

A new wound closure technique has been shown to significantly reduce complication rates in patients with non-idiopathic scoliosis undergoing spinal fusion surgery. The multilayered flap closure method eliminates 'dead space' and creates a better barrier, resulting in a 0% complication rate in patients who received the novel technique.

SourceNYU Langone Health / NYU Grossman School of Medicine·JournalJournal of Pediatric Orthopaedics·DateAug 20, 2015

Early evidence suggests hybrid cochlear implants may benefit millions with common form of hearing loss

A multicenter study found that hybrid cochlear implant devices led to significant improvements in hearing and speech recognition among individuals with severely damaged high-frequency hearing. The study showed that 45 participants experienced overall improvement in their hearing and speech recognition, with some achieving profound gains.

NYU Langone researchers to present new findings at 2015 Alzheimer's Association Conference

Researchers from NYU Langone Medical Center presented new findings on Alzheimer's disease treatment at the 2015 Alzheimer's Association Conference. The studies focused on the development of monoclonal antibodies that can recognize oligomeric tau and Aβ, as well as pathological structures in Parkinson's disease human brains. Additionall...